Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of Parkinson'S Disease|May 24, 2020
Deep Phenotyping of Parkinson's DiseaseE Ray Dorsey, Larsson Omberg, Emma Waddell, et al.
Brain : a Journal of Neurology|November 7, 2022
Mitochondrial haplogroups and cognitive progression in Parkinson's diseaseGanqiang Liu, Chunming Ni, Jiamin Zhan, et al.
Biochemical and Biophysical Research Communications|July 10, 2012
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's diseaseJi-Hyun Lee, Jong-Min Lee, Eliana Marisa Ramos, et al.
Nature Genetics|May 7, 2021
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's diseaseGanqiang Liu, Jiajie Peng, Zhixiang Liao, et al.
Biological Psychiatry|February 24, 2020
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's DiseaseNatalie Ellis, Amelia Tee, Branduff McAllister, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2004
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onsetNancy S Wexler, Judith Lorimer, Julie Porter, et al.
Archives of Neurology|July 21, 2004
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trialRobert G Holloway, Ira Shoulson, Stanley Fahn, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
JAMA Neurology|December 25, 2013
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial, Michael A Schwarzschild, Alberto Ascherio, et al.
JAMA|September 14, 2021
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial, Michael A Schwarzschild, Alberto Ascherio, et al.
Pageof 10